RANI
RANI
NASDAQ · Pharmaceuticals

Rani Therapeutics Holdings-A

$0.77
-0.01 (-1.01%)
As of Jun 22, 4:35 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +4,696.6% upside
Low Target $30.65
Average Target $37.15
High Target $44.71
Current Price $0.77
Current
$0.77
Target
$37.15
$30.65 $37.15 avg $44.71
Scenario Analysis
Bear Case
$30.65
3,857.4%
Low target
Base Case
$37.15
+4,696.6%
Avg target
Bull Case
$44.71
+5,672.8%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$3.87
-80.0% from high
52-Week Low
$0.39
+100.1% from low
Target vs 52W High
$37.15
+859.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%